CURRENT PHARMACEUTICAL BIOTECHNOLOGY, vol.21, no.12, pp.1176-1185, 2020 (Journal Indexed in SCI)
Article / Review
Title of Journal :
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
Nigella sativa, cancer, breast cancer, metastasis, natural killer cells, tumor surveillance, ACTIVITY IN-VITRO, TUMOR-CELLS, SEED-OIL, ANTIPROLIFERATIVE ACTIVITY, ANTICANCER ACTIVITY, OXIDATIVE STRESS, WILD PLANTS, THYMOQUINONE, L., CARCINOMA
Background: In the last decade, there have been accumulating data that the use of medicinal plants could bring additional benefits to the supportive treatment of various diseases. Nigella sativa (N. sativa, family Ranunculaceae) is one of these plants that has attracted considerable interest. The extracts and seeds of N. sativa and its active component thymoquinone have been studied extensively and the results suggest that N..cativa might carry some therapeutic potential for many diseases, including cancer.